CORDIS launches German Presidency R&D and Innovation Information Service

CORDIS, the Community Research and Development Information Service, has launched a new online service covering the research and innovation activities carried out under the German Presidency of the European Union (1 January - 30 June 2007).

Highlighting the latest news and most relevant developments in the research policy sphere during this period, the German Presidency Service is part of the gateway to national and regional activities on CORDIS.

The service highlights the R&D policies of the German Council Presidency and explains the research priorities that the German government will be pursuing during the country's time at the helm of the EU.

Throughout the Presidency, there will be numerous events, ranging from formal and informal ministerial meetings to open conferences, to support German efforts to develop and strengthen the European innovation environment.

The CORDIS German Presidency Service is a central gateway to research and development (R&D) and innovation activities carried out during the German Presidency. It provides up to date information about policy initiatives and highlights the latest R&D developments in a dedicated news section.

Links to other relevant websites, dealing with the German research scene and research policy in Germany, provide readers with important resources for further information about the R&D and innovation sector in the EU's biggest Member State. Analyses of the R&D system in Germany, as well as a comprehensive projects and results database and information on research funding, are also available, via the CORDIS national service for Germany.

Showcases provide an in-depth overview of particularly important initiatives, success stories or developments. Finally, an extensive contacts database enables users to locate and get in touch with relevant individuals or research organisations.

The German Presidency service on CORDIS is therefore a comprehensive gateway for everyone interested in R&D policy in Europe and in Germany. It was developed by CORDIS in cooperation with the relevant German authorities and is available in English and German.

For further information, please visit:
http://cordis.europa.eu/presidency/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...